Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

European Research Project Aims at Early Diagnosis of Memory Disorders

Published: Thursday, March 20, 2014
Last Updated: Thursday, March 20, 2014
Bookmark and Share
800 patients to participate in testing new diagnostic procedures.

The PredictND project, started by European research organizations, aims at developing and validating new procedures for the earlier diagnosis of memory disorders and for detecting individuals at high risk of developing memory disorders.

Millions of Europeans who are at risk for experiencing any kind of memory loss would benefit from such a solution. The novel approach will be tested on 800 patients in four hospitals in Finland, Denmark, the Netherlands and Italy. The PredictND project is coordinated by VTT Technical Research Centre of Finland and funded by the EU.

Diagnostics of memory disorders is complicated, as multiple reasons can explain the degeneration of cognitive capacity. Alzheimer’s disease is the most common reason explaining 60-70% of cases. Today no single test or biomarker can predict whether a particular person will develop Alzheimer´s disease.

On top of that, clinicians experience an overload of information: they need to combine information from multiple tests and biomarkers in order to find the correct reason and name for the disease.

The PredictND research project, co-funded under the European 7thFramework Programme, will not only develop new, cost-efficient methods for enabling earlier and more reliable diagnostics of different memory disorders in clinical practice; PredictND will also provide computer-based tools that help clinicians form a holistic view of the patient by combining information from several sources, such as clinical tests, imaging and blood samples, and by comparing these measurements to previously diagnosed cases available in hospital databases.

"Alongside the better prediction of memory disorders, PredictND wants to provide a completely new approach for clinicians to systematically manage the information load that they are facing in current clinical practice", says Dr Jyrki Lötjönen, Scientific Coordinator of PredictND, VTT. "For that, we intend to transfer state-of-the-art computer-based technologies, for example for image analysis and machine learning, to a modern hospital environment in order to assist clinicians in their daily work. At the earliest, the new diagnostics tool could enter the market in a couple of years.”

The novel approach will be tested on 800 patients in four top hospitals in Europe: Kuopio (Finland), Copenhagen (Denmark), Amsterdam (the Netherlands) and Perugia (Italy), and compared with the existing diagnostic procedures.

Early detection is crucial
"This project has been granted European funding because increasing the quality of life in Europe is high on our agenda, and memory disorders affect this seriously", explains Project Officer Amalia Vlad of the European Commission. "To treat these disorders, early detection and an accurate diagnosis are essential."

It is important to predict memory disorders before the symptoms start, especially in Alzheimer's disease where the pathological process leads to the death of brain cells. New cost-efficient methods are needed for detecting persons at high risk and corroborating this with new ways of intervention. PredictND will develop novel cost-efficient biomarkers for the early detection of persons at high risk.

One of the project partners, GE Healthcare, has already developed a PET amyloid imaging agent, a potentially powerful tool in aiding the diagnosis of Alzheimer's disease. "But results from this tool must be combined with other types of information to fully characterize the patient", says Dr Lennart Thurfjell, Head of Biomarkers and Software, Medical Diagnostics at GE Healthcare.

Big data
The use of modern machine learning techniques and the exploitation of large databases, i.e., "big data" as it is called nowadays, is still relatively limited in clinical practice. Hilkka Soininen, professor of neurology at the University of Eastern Finland, says: "The innovation of the project is to test the decision-making tool for the detection and differentiation of memory diseases at earliest phases. Detecting signs of progressive memory disease in time will allow earlier interventions and treatments. Tools which support decision-making will be common into tomorrow’s clinical practice. These tools can help a clinician to extract the most important information and profiles among the multitude of data.”

Dementia is a health priority in Europe. Alzheimer's disease alone accounts for costs equivalent to about 1% of the gross domestic product (GDP) of the whole world and the number of persons affected will double in the next 20 years. Alzheimer's disease affects more than five million people in Europe.

Partners
The PredictND research consortium is formed of eight top-level research, academic, industrial and medical organizations from five different European countries: VTT Technical Research Centre of Finland, GE Healthcare (UK), Imperial College London (UK), the University of Eastern Finland, Rigshospitalet (Denmark), VU Medical Center Amsterdam (the Netherlands), the University of Perugia (Italy) and Alzheimer Europe (Luxembourg).

The project will run for four years with a total budget of €4,219,646, to which the EU will contribute €3,148,000.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

VTT and GE Healthcare Developing Novel Biomarkers to Predict Alzheimer’s Disease
VTT and University of Eastern Finland scientists have discovered a serum biochemical signature.
Wednesday, June 27, 2012
Scientific News
Lemon Juice and Human Norovirus
Citric acid may prevent the highly contagious norovirus from infecting humans, scientists discovered from the German Cancer Research Center.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
Protein Found to Play a Key Role in Blocking Pathogen Survival
Calprotectin fends off microbial invaders by limiting access to iron, an important nutrient.
Study Identifies the Off Switch for Biofilm Formation
New discovery could help prevent the formation of infectious bacterial films on hospital equipment.
How DNA ‘Proofreader’ Proteins Pick and Edit Their Reading Material
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have discovered how two important proofreader proteins know where to look for errors during DNA replication and how they work together to signal the body’s repair mechanism.
Protein Found to Control Inflammatory Response
A new Northwestern Medicine study shows that a protein called POP1 prevents severe inflammation and, potentially, diseases caused by excessive inflammatory responses.
X-ray Laser Experiment Could Help in Designing Drugs for Brain Disorders
Scientists found that when two protein structures in the brain join up, they act as an amplifier for a slight increase in calcium concentration, triggering a gunshot-like release of neurotransmitters from one neuron to another.
Team Identifies Structure of Tumor-Suppressing Protein
An international group of researchers led by Carnegie Mellon University physicists Mathias Lösche and Frank Heinrich have established the structure of an important tumor suppressing protein, PTEN.
Why We’re Smarter Than Chickens
Toronto researchers have discovered that a single molecular event in our cells could hold the key to how we evolved to become the smartest animal on the planet.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!